These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 18601597)
1. APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels. Hubacek JA; Wang WW; Skodová Z; Adámková V; Vráblík M; Horínek A; Stulc T; Ceska R; Talmud PJ Clin Chem Lab Med; 2008; 46(6):773-7. PubMed ID: 18601597 [TBL] [Abstract][Full Text] [Related]
2. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia. Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587 [TBL] [Abstract][Full Text] [Related]
3. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia. Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811 [TBL] [Abstract][Full Text] [Related]
4. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects. Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444 [TBL] [Abstract][Full Text] [Related]
5. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114 [TBL] [Abstract][Full Text] [Related]
6. Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia. Evans D; Aberle J; Beil FU Atherosclerosis; 2011 Dec; 219(2):715-20. PubMed ID: 21993410 [TBL] [Abstract][Full Text] [Related]
7. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. Pisciotta L; Fresa R; Bellocchio A; Guido V; Priore Oliva C; Calandra S; Bertolini S Clin Chim Acta; 2011 Nov; 412(23-24):2194-8. PubMed ID: 21846464 [TBL] [Abstract][Full Text] [Related]
8. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population. Zhai G; Wen P; Guo L; Chen L Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641 [TBL] [Abstract][Full Text] [Related]
9. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans. Choi JR; Nam CM; Kang DR; Eom SM; Lee HJ; Park CM; Im JW; Jang Y Yonsei Med J; 2007 Aug; 48(4):609-18. PubMed ID: 17722232 [TBL] [Abstract][Full Text] [Related]
10. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041 [TBL] [Abstract][Full Text] [Related]
11. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study. Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872 [TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene. Priore Oliva C; Carubbi F; Schaap FG; Bertolini S; Calandra S J Intern Med; 2008 Apr; 263(4):450-8. PubMed ID: 18324930 [TBL] [Abstract][Full Text] [Related]
13. The c.553G>T Genetic Variant of the APOA5 Gene and Altered Triglyceride Levels in the Asian Population: A Meta-Analysis of Case-Control Studies. He H; Lei L; Chen E; Dong J; Zhang K; Yang J Genet Test Mol Biomarkers; 2016 Dec; 20(12):758-765. PubMed ID: 27813673 [TBL] [Abstract][Full Text] [Related]
14. Overweight modulates APOE and APOA5 alleles on the risk of severe hypertriglyceridemia. Lee MJ; Chien KL; Chen MF; Stephenson DA; Su TC Clin Chim Acta; 2013 Feb; 416():31-5. PubMed ID: 23178747 [TBL] [Abstract][Full Text] [Related]
15. Changes of plasma lipids during weight reduction in females depends on APOA5 variants. Suchanek P; Lorenzova A; Poledne R; Hubacek JA Ann Nutr Metab; 2008; 53(2):104-8. PubMed ID: 18946207 [TBL] [Abstract][Full Text] [Related]
16. Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain. Lamiquiz-Moneo I; Blanco-Torrecilla C; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Baila-Rueda L; Cenarro A; Civeira F; de Castro-Orós I Lipids Health Dis; 2016 Apr; 15():82. PubMed ID: 27108409 [TBL] [Abstract][Full Text] [Related]
17. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685 [TBL] [Abstract][Full Text] [Related]
18. Stepwise positive association between APOA5 minor allele frequencies and increasing plasma triglyceride quartiles in random patients with hypertriglyceridemia of unclarified origin. Hadarits F; Kisfali P; Mohás M; Maász A; Sümegi K; Szabó M; Hetyésy K; Valasek A; Janicsek I; Wittmann I; Melegh B Pathol Oncol Res; 2011 Mar; 17(1):39-44. PubMed ID: 20490738 [TBL] [Abstract][Full Text] [Related]
19. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes. Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Guardiola M; Heras M; Masana L Nutr Metab Cardiovasc Dis; 2010 May; 20(4):243-8. PubMed ID: 19765959 [TBL] [Abstract][Full Text] [Related]